Evidence map›Paper›PMID 39519064›Full record

ArticleInternational journal of molecular sciences2024

Enhanced ROS Production and Mitochondrial Metabolic Shifts in CD4

Ronja Söth, Anne L C Hoffmann, Cornelia A Deeg

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ronja SöthChair of Physiology, Department of Veterinary Sciences, Ludwig Maximilian University of Munich, D-82152 Martinsried, Germany.
Anne L C HoffmannChair of Physiology, Department of Veterinary Sciences, Ludwig Maximilian University of Munich, D-82152 Martinsried, Germany.
Cornelia A DeegChair of Physiology, Department of Veterinary Sciences, Ludwig Maximilian University of Munich, D-82152 Martinsried, Germany.ORCID 0000-0003-0375-3190

Funding

Deutsche Forschungsgemeinschaft DFG DE 719/4-4
6 · The paper itself

Abstract

Equine recurrent uveitis (ERU) is a spontaneously occurring autoimmune disease and one of the leading causes of blindness in horses worldwide. Its similarities to autoimmune-mediated uveitis in humans make it a unique spontaneous animal model for this disease. Although many aspects of ERU pathogenesis have been elucidated, it remains not fully understood and requires further research. CD4

Indexed as

Autoimmune DiseasesCD4-Positive T-LymphocytesDisease Models, AnimalMitochondriaReactive Oxygen SpeciesUveitisAnimalsFatty AcidsGlucoseGlycolysisHorse DiseasesHorsesOxidation-ReductionOxygen ConsumptionFatty AcidsGlucoseReactive Oxygen Speciesautoimmune uveitisautoimmunityCD4+ T cellequine recurrent uveitis (ERU)immunometabolismmetabolic flexibilityneuroinflammationreactive oxygen species

Identifiers

PMID39519064
PMCPMC11545935

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.